Analysis of the TCGA-LUAD database1 shows HACE1 somatic mutations in 2.1% of lung adenocarcinoma patients, suggesting a potential causal relationship with Rac1 hyperactivation. The gene discussed is RAC1; the disease is lung adenocarcinoma.